67 92

Cited 0 times in

Management of Blood Loss in Hip Arthroplasty: Korean Hip Society Current Consensus

DC FieldValueLanguage
dc.contributor.author박관규-
dc.date.accessioned2018-07-20T07:34:25Z-
dc.date.available2018-07-20T07:34:25Z-
dc.date.issued2017-
dc.identifier.issn2287-3260-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/160300-
dc.description.abstractThe volume of hip arthroplasty is stiffly increasing because of excellent clinical outcomes, however it has not been shown to decrease the incidence of transfusions due to bleeding related to this surgery. This is an important consideration since there are concerns about the side effects and social costs of transfusions. First, anemia should be assessed at least 30 days before elective hip arthroplasty, and if the subject is diagnosed as having anemia, an additional examination of the cause of the anemia should be carried and steps taken to address the anemia. Available iron treatments for anemia take 7 to 10 days to facilitate erythropoiesis, and preoperative iron supplementation, either oral or intravenous, is recommended. When using oral supplements for iron storage, administer elemental iron 100 mg daily for 2 to 6 weeks before surgery, and calculate the dose using intravenous supplement. Tranexamic acid (TXA) is a synthetic derivative of the lysine component, which reduces blood loss by inhibiting fibrinolysis and clot degradation. TXA is known to be an effective agent for reducing postoperative bleeding and reducing the need for transfusions in primary and revision total hip arthroplasties. Patient blood management has improved the clinical outcome after hip arthroplasty through the introduction and research of various agents, thereby reducing the need for allogeneic blood transfusions and reducing the risk of transfusion-related infections and the duration of hospitalizations.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisher대한고관절학회-
dc.relation.isPartOfHip & Pelvis-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleManagement of Blood Loss in Hip Arthroplasty: Korean Hip Society Current Consensus-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Orthopedic Surgery-
dc.contributor.googleauthorJoo-Hyoun Song-
dc.contributor.googleauthorJang Won Park-
dc.contributor.googleauthorYoung-Kyun Lee-
dc.contributor.googleauthorIn-Sung Kim-
dc.contributor.googleauthorJae-Hwi Nho-
dc.contributor.googleauthorKyung-Jae Lee-
dc.contributor.googleauthorKwan Kyu Park-
dc.contributor.googleauthorYeesuk Kim-
dc.contributor.googleauthorJai Hyung Park-
dc.contributor.googleauthorSeung Beom Han-
dc.identifier.doi10.5371/hp.2017.29.2.81-
dc.contributor.localIdA01428-
dc.relation.journalcodeJ00989-
dc.identifier.eissn2287-3279-
dc.identifier.pmid28611958-
dc.subject.keywordBlood management-
dc.subject.keywordHip arthroplasty-
dc.subject.keywordTransfusion-
dc.contributor.alternativeNamePark, Kwan Kyu-
dc.contributor.affiliatedAuthorPark, Kwan Kyu-
dc.citation.volume29-
dc.citation.number2-
dc.citation.startPage81-
dc.citation.endPage90-
dc.identifier.bibliographicCitationHip & Pelvis, Vol.29(2) : 81-90, 2017-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Orthopedic Surgery (정형외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.